Shigematsu A[au] - Search Results

Year	Number of Results
1958	1
1963	1
1965	1
1966	1
1967	1
1969	2
1970	1
1972	2
1973	2
1974	5
1976	2
1977	7
1978	1
1979	1
1981	2
1982	3
1983	3
1984	5
1985	8
1986	5
1987	3
1988	4
1989	6
1990	5
1991	6
1992	8
1993	4
1994	9
1995	14
1996	6
1997	3
1998	11
1999	11
2000	9
2001	16
2002	19
2003	9
2004	9
2005	10
2006	9
2007	10
2008	12
2009	4
2010	7
2011	11
2012	9
2013	5
2014	6
2015	7
2016	5
2017	3
2018	3
2019	1
2020	1
2021	1
2022	2
2023	7
2024	1

1

Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia.

Aiba M, Shigematsu A, Suzuki T, Miyagishima T. Aiba M, et al. Among authors: shigematsu a. Ann Hematol. 2023 Mar;102(3):541-546. doi: 10.1007/s00277-023-05102-y. Epub 2023 Jan 16. Ann Hematol. 2023. PMID: 36646889 Free PMC article.

2

Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.

Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Goto H, Sugita J, Fujisawa S, Hidaka D, Ogasawara R, Mori A, Matsuoka S, Shigematsu A, Wakasa K, Kasahara I, Saga T, Hashiguchi J, Takeda Y, Ibata M, Yutaka T, Fujimoto K, Kondo T, Teshima T. Miyajima T, et al. Among authors: shigematsu a. Eur J Haematol. 2023 Oct;111(4):620-627. doi: 10.1111/ejh.14055. Epub 2023 Jul 19. Eur J Haematol. 2023. PMID: 37465857

3

Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present.

Imamura M, Shigematsu A. Imamura M, et al. Among authors: shigematsu a. J Clin Med. 2019 Apr 26;8(5):569. doi: 10.3390/jcm8050569. J Clin Med. 2019. PMID: 31027384 Free PMC article. Review.

4

Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.

Yokoyama S, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Matsukawa T, Goto H, Fujisawa S, Miki K, Hidaka D, Hashiguchi J, Wakasa K, Ibata M, Takeda Y, Shigematsu A, Fujimoto K, Tsutsumi Y, Mori A, Ishihara T, Kakinoki Y, Kondo T, Hashimoto D, Teshima T. Yokoyama S, et al. Among authors: shigematsu a. Br J Haematol. 2023 Jun;201(6):1144-1152. doi: 10.1111/bjh.18800. Epub 2023 Apr 17. Br J Haematol. 2023. PMID: 37067758

5

Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor.

Nonoyama S, Hotta K, Iwahara N, Tanabe T, Hirose T, Harada S, Junichi S, Nakazawa D, Shigematsu A, Otsuka T, Shinohara N. Nonoyama S, et al. Among authors: shigematsu a. Nephron. 2023;147(10):621-626. doi: 10.1159/000531031. Epub 2023 May 11. Nephron. 2023. PMID: 37231903

6

[Endogenous inhibitory system in pain].

Tsubaki T, Tanaka T, Shigematsu A. Tsubaki T, et al. Among authors: shigematsu a. J UOEH. 1986 Jun 1;8(2):229-38. doi: 10.7888/juoeh.8.229. J UOEH. 1986. PMID: 3529278 Review. Japanese.

7

Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

Ogata M, Matsumoto T, Kamochi M, Yoshida SI, Mizuguchi Y, Shigematsu A. Ogata M, et al. Among authors: shigematsu a. Infect Immun. 1992 Jun;60(6):2432-7. doi: 10.1128/iai.60.6.2432-2437.1992. Infect Immun. 1992. PMID: 1587610 Free PMC article.

8

Kynurenine promotes Calcitonin secretion and reduces cortisol in the Japanese flounder Paralichthys olivaceus.

Ikari T, Furusawa Y, Tabuchi Y, Maruyama Y, Hattori A, Kitani Y, Toyota K, Nagami A, Hirayama J, Watanabe K, Shigematsu A, Rafiuddin MA, Ogiso S, Fukushi K, Kuroda K, Hatano K, Sekiguchi T, Kawashima R, Srivastav AK, Nishiuchi T, Sakatoku A, Yoshida MA, Matsubara H, Suzuki N. Ikari T, et al. Among authors: shigematsu a. Sci Rep. 2023 May 29;13(1):8700. doi: 10.1038/s41598-023-35222-4. Sci Rep. 2023. PMID: 37248272 Free PMC article.

9

Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia.

Yoshida S, Onozawa M, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Kobayashi H, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Ota S, Kondo T, Teshima T. Yoshida S, et al. Among authors: shigematsu a. Int J Hematol. 2023 Apr;117(4):544-552. doi: 10.1007/s12185-022-03522-6. Epub 2022 Dec 26. Int J Hematol. 2023. PMID: 36572814

10

Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning.

Imamura M, Shigematsu A. Imamura M, et al. Among authors: shigematsu a. Exp Hematol Oncol. 2015 Jul 16;4:20. doi: 10.1186/s40164-015-0015-0. eCollection 2015. Exp Hematol Oncol. 2015. PMID: 26322249 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

307 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year